NFKB1 and atherosclerosis: This was confirmed by WB that YQWY reduced the degradation of IκBα and phosphorylation of p65 within the NF-κB pathway in a dose-dependent manner in the aorta of mice with atherosclerosis (Figure 5(C and D)).